11th Swiss Pharma Science Day 2018 – “Cancer”
This year’s Swiss Pharma Science Day is focused on Cancer with the following presentations:
«National Strategy Against Cancer»
Dr. sc.nat. Michael Röthlisberger, Nationale Strategie gegen Krebs, Krebsliga, Bern
«Non-biological Complex Nanomedicines and Their Preclinical Evaluation»
Dr. Scott McNeil, NCL-NCI Frederick MD, U.S.A.
«Lessons to be Learned: The Molecular Basis of Kinase-Targeted Therapies and Drug Resistance in Non-Small Cell Lung Cancer»
Prof. Dr. Daniel Rauh, TU Dortmund
«Development of Oral LFA-1 Inhibitors»
Prof. Dr. pharm. et med. Stephan Krähenbühl, University Hospital & University of Basel
«Nonadherence to Oral Targeted Anticancer Drugs: What’s the Problem and How to Address It ?»
Dr. Marie-Paule Schneider, Policlinique MédicaleUniversitaire and EPGL University of Geneva
More Information & Registration & Poster Session
If you like to Sponsor the Event, please get in touch via Email to [email protected]
